BRISTOL-MYERS SQUIBB CO
BRISTOL-MYERS SQUIBB CO
Share · US1101221083 · BMY · 850501 (XNYS)
Overview Financial Indicators
48,36 USD
1,00 % 0,48 USD
NYSE (XNYS) · Current prices and charts at MoneyPeak
06.06.2025 22:18

Current Prices from BRISTOL-MYERS SQUIBB CO

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
BMY
USD
06.06.2025 22:18
48,36 USD
47,84 USD
+1,09 %
XETR: XETRA
XETRA
BRM.DE
EUR
06.06.2025 15:35
42,45 EUR
42,31 EUR
+0,32 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,14 % 1,34 % -19,15 % -18,10 % 16,70 % -21,15 %

Company Profile for BRISTOL-MYERS SQUIBB CO Share

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

Invested Funds

The following funds have invested in: BRISTOL-MYERS SQUIBB CO invested:

Fund
iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)
Vol. in million
34.308,76
Percentage (%)
2,38 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
6.889,62
Percentage (%)
1,89 %
Fund
iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)
Vol. in million
2.069,92
Percentage (%)
1,68 %
Fund
iShares MSCI World Quality Dividend UCITS ETF USD (Acc)
Vol. in million
598,56
Percentage (%)
1,26 %
Fund
iShares Edge MSCI World Value Factor UCITS ETF USD (Dist)
Vol. in million
2.556,87
Percentage (%)
0,98 %

Company Data

Name BRISTOL-MYERS SQUIBB CO
Company Bristol-Myers Squibb Company
Symbol BMY
Website https://www.bms.com
Primary Exchange XNYS NYSE
WKN 850501
ISIN US1101221083
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Dr. Christopher S. Boerner Ph.D.
Market Capitalization 89 Mrd.
Country United States of America
Currency USD
Employees 34,1 T
Address 430 East 29th Street, 10016 New York
IPO Date 1999-05-14
Dividends from 'BRISTOL-MYERS SQUIBB CO'
Ex-Date Dividend per Share
04.04.2025 0,62 USD
03.01.2025 0,62 USD
04.10.2024 0,60 USD
05.07.2024 0,60 USD
04.04.2024 0,60 USD
04.01.2024 0,60 USD
05.10.2023 0,57 USD
06.07.2023 0,57 USD
06.04.2023 0,57 USD
05.01.2023 0,57 USD

Stock Splits

Date Split
07.08.2001 1000000:951777
01.03.1999 2:1
03.03.1997 2:1
10.06.1987 2:1
27.05.1983 2:1
31.05.1977 2:1

Ticker Symbols

Name Symbol
Frankfurt BRM.F
NYSE BMY
XETRA BRM.DE

More Shares

Investors who BRISTOL-MYERS SQUIBB CO hold also have the following shares in their portfolio:
ADOBE INC
ADOBE INC Share
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Share
AMAZON.CO INC
AMAZON.CO INC Share
AMERICAN STATES WATER CO
AMERICAN STATES WATER CO Share
APPLE INC
APPLE INC Share
COCA-COLA CO
COCA-COLA CO Share
FLOSSB.V.ST.-MU.AS.GR.R
FLOSSB.V.ST.-MU.AS.GR.R Fund
META PLATFORMS INC
META PLATFORMS INC Share
MFS M.-CONT.EUR.EQU.A1 EO
MFS M.-CONT.EUR.EQU.A1 EO Fund
MICROSOFT CORP
MICROSOFT CORP Share
MOBILUX FIN. 21/28 REGS
MOBILUX FIN. 21/28 REGS Bond
NVIDIA CORP
NVIDIA CORP Share
TESLA INC
TESLA INC Share
WALT DISNEY INC
WALT DISNEY INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025